Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Completed · Phase 3 · Has a placebo group
Conditions studied: Uterine Fibroids, Heavy Menstrual Bleeding
In brief
The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
Key facts
- Study ID
- NCT03070951
- Run by
- ObsEva SA
- People needed
- 511
- Starts
- 2017-05-23
- Expected to finish
- 2020-10-04
- Last updated by the study team
- 2021-03-05
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Site reference ID 918 — Huntington Park, California, United States
- Site reference ID 902 — San Diego, California, United States
- Site reference ID 903 — Denver, Colorado, United States
- Site reference ID 913 — Bradenton, Florida, United States
- Site reference ID 912 — Orlando, Florida, United States
- Site reference ID 915 — Augusta, Georgia, United States
- Site reference ID 924 — Nampa, Idaho, United States
- Site reference ID 926 — Covington, Louisiana, United States
- Site reference ID 927 — Metairie, Louisiana, United States
- Site reference ID 900 — Metairie, Louisiana, United States
- Site reference ID 901 — Canton, Michigan, United States
- Site reference ID 932 — Detroit, Michigan, United States
- Site reference ID 916 — Jefferson City, Missouri, United States
- Site reference ID 930 — Albuquerque, New Mexico, United States
- Site reference ID 933 — West Seneca, New York, United States
- Site reference ID 931 — Hamlet, North Carolina, United States
- Site reference ID 914 — Westerville, Ohio, United States
- Site reference ID 928 — Erie, Pennsylvania, United States
- Site reference ID 919 — West Columbia, South Carolina, United States
- Site reference ID 907 — Houston, Texas, United States
- Site reference ID 911 — Salt Lake City, Utah, United States
- Site reference ID 917 — Madison, Wisconsin, United States
- Site reference ID 265 — Gabrovo, Bulgaria
- Site reference ID 255 — Pleven, Bulgaria
- Site reference ID 905 — Chino, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.